Table 6.
The frequencies of the 2ry glomerulonephritis subtypes
| GN categories | GN subtypes | Date category | Total | P | |
|---|---|---|---|---|---|
| Period 1 (1988-1999), n (%) | Period 2 (2000-2014), n (%) | ||||
| Secondary GN | LN | 37 (66.1)a | 156 (75.4)b | 193 | 0.492 |
| DN | 8 (14.3)a | 19 (9.2)a | 27 | ||
| HTN | 2 (3.6)a | 7 (3.4)a | 9 | ||
| AS | 1 (1.8)a | 2 (1.0)a | 3 | ||
| CGN-AGBM | 0 (0.0)a | 1 (0.5)a | 1 | ||
| CGN-V | 3 (5.4)a | 4 (1.9)a | 7 | ||
| AM | 3 (5.4)a | 11 (5.3)a | 14 | ||
| CRYO | 2 (3.6)a | 1 (0.5)a | 3 | ||
| LCDD | 0 (0.0)a | 2 (1.0)a | 2 | ||
| MM | 0 (0.0)a | 3 (1.4)a | 3 | ||
| H.SDROSIS | 0 (0.0)a | 1 (0.5)a | 1 | ||
| Total (n) | 56 | 207 | 263 | ||
a, b=Groups with same letter no significant difference. AS: Alport syndrome, GN: Glomerulonephritis, CGN-AGBM: Crescentic GN-antiglomerular basement membrane, CRYO: Cryoglobulinemia, LCDD: Light-chain deposit disease, H.SDROSIS: Hemosiderosis, MM: Multiple myeloma, AM: Amyloid, LN: Lupus nephritis, HTN: Hypertension nephropathy, DN: Diabetic nephropathy, CGN-V: Crescentic GN with vasculitis